Samrudh Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-12-2024
- Paid Up Capital ₹ 3.09 M
as on 29-12-2024
- Company Age 27 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.50 Cr
as on 29-12-2024
- Revenue 84.68%
(FY 2022)
- Profit 85.84%
(FY 2022)
- Ebitda 62.97%
(FY 2022)
- Net Worth 45.07%
(FY 2022)
- Total Assets 45.40%
(FY 2022)
About Samrudh Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.09 M.
The company has closed loans amounting to ₹5.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Narendra Jain, Sharad Sheth, Satish Dave, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH1997PTC111971
- Company No.
111971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Samrudh Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Sheth  | Director | 15-Feb-2021 | Current |
| Narendra Jain | Director | 06-May-2011 | Current |
| Sharad Sheth | Director | 19-Nov-1997 | Current |
| Satish Dave | Director | 22-Jan-2004 | Current |
Financial Performance of Samrudh Healthcare.
Samrudh Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 84.68% increase. The company also saw a substantial improvement in profitability, with a 85.84% increase in profit. The company's net worth Soared by an impressive increase of 45.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samrudh Healthcare?
In 2022, Samrudh Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Samrudh Pharmaceuticals Private LimitedActive 33 years 8 monthsSharad Sheth and Alok Sheth are mutual person
- Samrudh Pharmacare Private LimitedActive 29 years 8 months
Sharad Sheth and Alok Sheth are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 24 Oct 2011 | ₹2.75 Cr | Satisfied |
Bank Of India Creation Date: 24 Oct 2011 | ₹2.75 Cr | Satisfied |
How Many Employees Work at Samrudh Healthcare?
Unlock and access historical data on people associated with Samrudh Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samrudh Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrudh Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
